Methanesulfonyl Fluoride

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Methanesulfonyl Fluoride
Accession Number
DB13058
Type
Small Molecule
Groups
Investigational
Description

Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.

Structure
Thumb
Synonyms
Not Available
External IDs
SNX-001
Categories
UNII
9H250YYY0R
CAS number
558-25-8
Weight
Average: 98.09
Monoisotopic: 97.983778674
Chemical Formula
CH3FO2S
InChI Key
KNWQLFOXPQZGPX-UHFFFAOYSA-N
InChI
InChI=1S/CH3FO2S/c1-5(2,3)4/h1H3
IUPAC Name
methanesulfonyl fluoride
SMILES
CS(F)(=O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
16-BromoepiandrosteroneThe risk or severity of adverse effects can be increased when 16-Bromoepiandrosterone is combined with Methanesulfonyl Fluoride.
19-norandrostenedioneThe risk or severity of adverse effects can be increased when 19-norandrostenedione is combined with Methanesulfonyl Fluoride.
5-androstenedioneThe risk or severity of adverse effects can be increased when 5-androstenedione is combined with Methanesulfonyl Fluoride.
AcebutololMethanesulfonyl Fluoride may increase the bradycardic activities of Acebutolol.
AcetylcholineThe risk or severity of adverse effects can be increased when Methanesulfonyl Fluoride is combined with Acetylcholine.
AclidiniumThe therapeutic efficacy of Aclidinium can be decreased when used in combination with Methanesulfonyl Fluoride.
AgmatineThe therapeutic efficacy of Agmatine can be decreased when used in combination with Methanesulfonyl Fluoride.
AlclometasoneThe therapeutic efficacy of Methanesulfonyl Fluoride can be decreased when used in combination with Alclometasone.
AlcuroniumThe therapeutic efficacy of Alcuronium can be decreased when used in combination with Methanesulfonyl Fluoride.
AldosteroneThe risk or severity of adverse effects can be increased when Aldosterone is combined with Methanesulfonyl Fluoride.
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
11207
PubChem Substance
347829186
ChemSpider
10734

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentSafety1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility5.16 mg/mLALOGPS
logP0.5ALOGPS
logP-0.48ChemAxon
logS-1.3ALOGPS
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area34.14 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity15.47 m3·mol-1ChemAxon
Polarizability6.95 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as sulfonyl fluorides. These are compounds containing a sulfonyl (R-S(=O)2-R') functional group singly bonded to a fluorine atom.
Kingdom
Organic compounds
Super Class
Organohalogen compounds
Class
Sulfonyl halides
Sub Class
Sulfonyl fluorides
Direct Parent
Sulfonyl fluorides
Alternative Parents
Sulfonyls / Organosulfonic acids and derivatives / Organic oxides / Hydrocarbon derivatives
Substituents
Sulfonyl / Sulfonyl fluoride / Organosulfonic acid or derivatives / Organic sulfonic acid or derivatives / Organic oxygen compound / Organic oxide / Hydrocarbon derivative / Organosulfur compound / Aliphatic acyclic compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 20:30 / Updated on October 01, 2018 15:25